Cover Story
Editorial
On Nov. 5, as the American people expressed their will, electing Donald Trump to a second term, I started to wonder what my friends in oncology were thinking.
In Brief
Clinical Roundup
Trending Stories
- How the 2024 elections can impact cancer policy
- Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S. - GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- At his 25-year “anniversary party,” Pazdur invites Califf and past FDA commissioners to talk about political interference
- “Less Radical” podcast: Resistance to change, a data scandal